Equillium, a biotech that?s looking to develop an antibody drug for immuno-inflammatory diseases, has added a form of renal disease to the indications for which it aims to develop medicines. It?s the latest step in a fast-moving journey for the La Joll… […]
When her parents asked Amanda Walker if she?d like try an experimental treatment for her rare bone disease, the girl was terrified. As they had been counseled, Amanda?s parents, Alicia and Robert Walker, dropped the matter for the time being. But a… […]
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24ILMN&src=ctag" target="_blank"gt;$ILMNlt;/agt; lt;a href="https://twitter.com/hashtag/ILMN?src=hash" target="_blank"gt;#ILMNlt;/agt;–Ill… […]
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/OSA?src=hash" target="_blank"gt;#OSAlt;/agt;–Experimental photonic switches tested by researchers at the University of California, Berkeley, U.S.A., show promise to… […]
1. Will Donate DNA for Cash Your health data is worth money, so why not get a cut of the profit? Solana Beach-based Luna DNA, a public benefit corporation, lets donors of DNA, medical records, and other information earn shares of the company in return…. […]
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/OSA?src=hash" target="_blank"gt;#OSAlt;/agt;–Searching for better security during data transmission, governments and other organizations around the world have been … […]
SACRAMENTO, Calif. & SAN DIEGO & SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CALeg?src=hash" target="_blank"gt;#CALeglt;/agt;–California Life Sciences Association Recognizes Senator Jeff Stone and… […]
San Diego-based Adamis has stumbled in its attempt to get a lower-cost erectile dysfunction drug on the market.
The specialty pharmaceutical company ? which focuses on developing cheaper drugs for various disorders ? said the FDA had deemed its marketi… […]
The idea was simple: What if the conference organizers only invited women on stage? The reaction was complicated. […]
There?s no way around it: Developing medicine is costly. The average drug takes about $2.6 billion to develop through FDA approval, according to the Tufts Center for the Study of Drug Development. With a price tag that high, securing venture capital (V… […]
Gene sequencing giant Illumina and Rady Children’s Institute for Genomic Medicine have helped launch an international program to standardize the use of genome sequencing in medicine. The Medical Genome Initiative, announced Tuesday, aims to turn wh… […]
Millennium Health is a specialty laboratory serving clinicians treating patients with chronic pain, behavioral health, or substance use disorders. Since 2007, the company has leveraged extensive clinical expertise in combination with significant labora… […]
Join Scilligence for a day of discussions, lunch, raffles, and networking with fellow professionals in biotech and pharma! Learn how Scilligence’s integrated platform can improve internal/external collaboration, IP protection, and knowledge sharing. Le… […]
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/OSA?src=hash" target="_blank"gt;#OSAlt;/agt;–OFC 2019, the premier event in telecom and data center optics, being held 5-7 March at the San Diego Convention Center,… […]
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/California?src=hash" target="_blank"gt;#Californialt;/agt;–Biocom appoints Christophe Schilling, Ph.D., as chair of the organization’s board of directors, makes add… […]
As the fast-moving Ebola virus sweeps through eastern Congo, scientists are braving into war zones hoping to test new medicines ? including one designed in San Diego ? in sick patients there. Despite civil unrest in the region, Doctors Without Bord… […]
SAN DIEGO–(BUSINESS WIRE)–Eight leading health care and research organizations in the U.S. and Canada have signed an agreement to launch the Medical Genome Initiative, a consortium that will work to expand access to high-quality clinical whole genome… […]
LA JOLLA, Calif.–(BUSINESS WIRE)–Trio Health, a leading provider of retrospective observational data on real world patients, today announced results from several of its research programs that reveal critical, and often counterintuitive, insights rega… […]
Novartis has agreed to pay $150 million to Ionis Pharmaceuticals and Boston-based Akcea Therapeutics for the rights to a clinical-stage drug meant to treat patients with abnormally high levels of a protein that is considered a risk factor for cardiovas… […]
LA JOLLA?The Salk Institute Board of Trustees is pleased to announce its two newest members, David Dolby and Mark Knickrehm, both innovative leaders in business and technology.
The post Technology and business giants David Dolby and Mark Knickrehm join… […]
Novartis has taken up its option to license antisense oligonucleotide TQJ230, triggering a $150 million payout that Akcea Therapeutics will share with Ionis Pharmaceuticals. The decision sets Novartis up to test the RNA-targeting drug in […]
Novartis will pay $150 million to license a heart disease medication discovered by Carlsbad?s Ionis Pharmaceuticals, the Swiss drug giant said Monday. The experimental drug was co-developed by Ionis with its majority-owned subsidiary Akcea Therapeu… […]
Section 32, the venture capital fund based in San Diego?s Cardiff-by-the-Sea community, has raised nearly $200 million for its second fund. A document filed with securities regulators Friday shed light on comments made the previous week to Xconomy by S… […]
DNA is spelled out with four letters, or bases. Researchers have now built a system with eight. It may hold clues to the potential for life elsewhere in the universe and could also expand our […]
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/OSA?src=hash" target="_blank"gt;#OSAlt;/agt;–New work leveraging machine learning could increase the efficiency of optical telecommunications networks. As our world… […]
Copyright © 2023 Biotech Networks, LLC
